These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 18942347

  • 1. [Current treatment of systemic sclerosis. Part II. Vascular and antifibrotic treatment].
    Sicińska J, Rudnicka L.
    Pol Merkur Lekarski; 2008 Aug; 25(146):196-200. PubMed ID: 18942347
    [Abstract] [Full Text] [Related]

  • 2. [Systemic sclerosis].
    Tamborrini G, Distler M, Distler O.
    Med Monatsschr Pharm; 2008 May; 31(5):162-70; quiz 171-2. PubMed ID: 18552072
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Therapeutic management of acral manifestations of systemic sclerosis].
    Meyer MF, Daigeler A, Lehnhardt M, Steinau HU, Klein HH.
    Med Klin (Munich); 2007 Mar 15; 102(3):209-18. PubMed ID: 17345017
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Future targets in the management of systemic sclerosis.
    Tyndall A, Matucci-Cerinic M, Müller-Ladner U.
    Rheumatology (Oxford); 2009 Jun 15; 48 Suppl 3():iii49-53. PubMed ID: 19487225
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. New therapeutic strategies for systemic sclerosis--a critical analysis of the literature.
    Zandman-Goddard G, Tweezer-Zaks N, Shoenfeld Y.
    Clin Dev Immunol; 2005 Sep 15; 12(3):165-73. PubMed ID: 16295521
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Systemic sclerosis: symptomatic treatment].
    Dziankowska-Bartkowiak B, Waszczykowska E, Skretkowicz K.
    Pol Merkur Lekarski; 2003 Sep 15; 15(87):259-62. PubMed ID: 14679853
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute.
    AHA, ACC, National Heart, Lung, and Blood Institute, Smith SC, Allen J, Blair SN, Bonow RO, Brass LM, Fonarow GC, Grundy SM, Hiratzka L, Jones D, Krumholz HM, Mosca L, Pearson T, Pfeffer MA, Taubert KA.
    J Am Coll Cardiol; 2006 May 16; 47(10):2130-9. PubMed ID: 16697342
    [No Abstract] [Full Text] [Related]

  • 17. Management of Raynaud's phenomenon and digital ulcers in systemic sclerosis.
    Botzoris V, Drosos AA.
    Joint Bone Spine; 2011 Jul 16; 78(4):341-6. PubMed ID: 21183379
    [Abstract] [Full Text] [Related]

  • 18. [Evidence-based therapy of systemic sclerosis].
    Genth E.
    Z Rheumatol; 2001 Dec 16; 60(6):464-8. PubMed ID: 11826742
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Treatment of systemic sclerosis].
    Medrano Ramírez G, Lidia Vera-Lastra O, Jara LJ.
    Reumatol Clin; 2006 Nov 16; 2 Suppl 3():S42-5. PubMed ID: 21794387
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.